Concord Drugs Ltd. - Research Center
538965 CONCORD Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 9.32 | 8.74 | 8.74 | 8.74 | 7.86 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 22.39 | 19.62 | 18.02 | 14.74 | 15.29 |
| Loan funds | |||||
| Secured loans | 14.80 | 16.43 | 12.97 | 9.57 | 9.83 |
| Unsecured loans | - | - | - | - | - |
| Total | 46.51 | 44.79 | 39.74 | 33.05 | 32.98 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 37.61 | 37.12 | 35.22 | 10.52 | 11.85 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 24.75 | 23.15 | 21.39 | - | - |
| Net block | 12.86 | 13.97 | 13.83 | 10.52 | 11.85 |
| Capital work-in-progress | 0.92 | 0.55 | - | 1.00 | 0.29 |
| Investments | 1.42 | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 41.44 | 41.92 | 36.05 | 46.49 | 70.63 |
| Less : current liabilities & provisions | 10.13 | 11.65 | 10.14 | 24.96 | 49.79 |
| Total net current assets | 31.31 | 30.27 | 25.91 | 21.53 | 20.84 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 46.51 | 44.79 | 39.74 | 33.05 | 32.98 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 93.15 | 87.44 | 87.44 | 87.44 | 78.62 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis